Loading clinical trials...
Loading clinical trials...
This is a Phase 1/2, open-label, dose escalation study to evaluate the safety, efficacy and tolerability of BMN 307 in adult PKU subjects with PAH deficiency. Participants will receive a single admini...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
BioMarin Pharmaceutical
NCT06628128 · Phenylketonuria (PKU)
NCT05813678 · Phenylketonuria (PKU)
NCT05270837 · Phenylketonuria (PKU)
NCT06792240 · Phenylketonuria (PKU)
NCT04086511 · Phenylketonuria (PKU)
University of South Florida
Tampa, Florida
Morristown Medical Center
Morristown, New Jersey
University Hospital Birmingham NHS Foundation Trust
Birmingham
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions